MSN/FOX19: Johnson & Johnson COVID-19 vaccine still very effective, UC professor says
UC expert says the important thing is getting as many people vaccinated as possible
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine, was interviewed for a story on the COVID-19 vaccine from by Johnson & Johnson which showed an effective rate of 66%. WXIX-TV/FOX19 produced the story locally which was picked up by MSN nationally.
Fichtenbaum says it's still worthwhile for people to get the J & J vaccine despite that comparitively low effectiveness rate
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine/Photo/Joe Fuqua II/UC Creative + Brand
With Moderna testing at 94% effective and Pfizer testing at 95%, Fichtenbaum expects that people will have a preference in which vaccine they will receive.
“When we continue to test new vaccines, we’re testing them in a different environment where there are these strains that are emerging where the vaccine may not respond as well,” Fichtenbaum says. “So, if we tested Moderna or Pfizer vaccine under those conditions, would they still be the same as 95%? I’m not so certain.”
Lead photo/Getty Images
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
How are tariffs impacting your retirement plans?
May 15, 2025
WVXU sat down with University of Cincinnati’s Michael Neugent for a look into how tariffs impact the markets, retirement funds and inflation. Neugent, associate professor-educator at Lindner College of Business and Director of the MS Finance Program, said that investors in the stock market prefer certainty in fiscal policy to help them map out investment decisions. “Right now, that lack of certainty is providing some angst within the market and investors,” he told WVXU. Many U.S. companies will face challenges from tariffs, but pauses on tariff plans can sometimes lead to more questions than answers.
University of Cincinnati project aims to aid people with spinal...
May 15, 2025
Spectrum News and Fox 19 highlighted University of Cincinnati research designing a user-centered, easy-to-use assistive device to help restore hand grasping motions for people with spinal cord injuries/diseases.
Hoxworth Co-Director David Oh, MD, named to America's Blood...
May 14, 2025
Hoxworth Blood Center, University of Cincinnati, is proud to announce that David Oh, MD, interim co-director and chief medical officer, has been appointed to America’s Blood Centers (ABC) Board of Directors.